▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for HOYA in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $112.50.
The current consensus among 2 investment analysts is to buy stock in HOYA. This rating has held steady since June 2020, when it changed from a Hold consensus rating.
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company operates through three segments: Life Care, Information Technology, and Other. The Life Care segment offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endoscopes, laparoscopic surgical instruments, intraocular lenses, and prosthetic ceramic fillers and orthopedic implants. This segment also operates Â'Eyecity', a chain of specialist contact lens stores. The Information Technology segment provides electronics products comprising mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; and glass disks for hard disk drives. This segment also offers imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. The Other segment provides various IT solutions, which comprise system architecture and information processing, business application software, ERP solutions, and internet services; speech synthesis software; and cloud services. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.